Study links biomarkers to long-term kidney damage and death in critically ill

January 14, 2015

High levels of two novel urinary biomarkers early in critical illness are associated with adverse long-term outcomes in patients with acute kidney injury (AKI), according to an international, multi-center study led by University of Pittsburgh School of Medicine Researchers. AKI is a condition that often affects those in intensive care and can occur hours to days after serious infections, surgery or taking certain medications.

The results, available online in the Journal of the American Society of Nephrology, show that the combination of tissue inhibitor metalloproteinase-2 (TIMP-2) and IGF-binding protein-7 (IGFBP7) can identify with AKI who are at increased risk for death or requiring renal replacement therapy, such as dialysis or kidney transplant, over the next nine months. The two biomarkers are indicators of cell stress and injury, key components in the development of AKI.

AKI is largely asymptomatic, lacking warning signs such as pain, shortness of breath or other clinical symptoms, particularly in the early stages when intervention is most beneficial. The incidence of AKI is high among , with up to 50 percent developing some degree of AKI during their illness, increasing the risk of death due to kidney failure.

"We found that not only do these biomarkers predict the development of AKI but, at high levels, they also tell us about long-term prognosis," said senior investigator John Kellum, M.D., a critical care physician at UPMC and director of the Center for Critical Care Nephrology at the University of Pittsburgh. "This should greatly aid clinicians and researchers attempting to address this too-common complication."

Investigators enrolled 692 critically ill patients at 35 medical centers in North America and Europe. The primary analysis assessed the outcomes of patients using an FDA-approved biomarker test, known as NEPHROCHECK, within the first day of arrival into the unit. The team found strong associations between the biomarker combination and the risk of renal replacement therapy or death.

Explore further: Study identifies biomarkers that can provide advance warning of deadly kidney condition

Related Stories

Acute kidney injury may be more deadly than heart attacks

December 5, 2013

Acute kidney injury, a condition that is common but often asymptomatic, may be more deadly than a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology ...

New markers for acute kidney injury reported

March 4, 2014

Saeed A. Jortani, Ph.D., associate clinical professor in the University of Louisville's Department of Pathology and Laboratory Medicine, headed up one of three labs in the United States involved in determining two new markers ...

Recommended for you

New way of screening potential treatments for tuberculosis

March 29, 2017

Scientists from LSTM's Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB) which may assist in ...

Discovery may help patients beat deadly pneumonia

March 28, 2017

Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.